enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Prescription drug prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Prescription_drug_prices...

    Within the year of 2014, the cost of prescriptions had increased by at least 11.4% and 58% within the last eight years. The average cost for a month supply of brand-name drugs can run up to a couple of hundred US dollars, whereas in Canada and Great Britain the same medication could cost up to $40 US dollars.

  3. Merck posts better-than-expected results on Keytruda ... - AOL

    www.aol.com/news/merck-posts-better-expected...

    Keytruda sales rose 21% to $6.6 billion as the company was able to increase use of the drug in earlier stage cancers, topping analyst forecasts of $6.5 billion. ... The New Jersey-based drugmaker ...

  4. Pembrolizumab - Wikipedia

    en.wikipedia.org/wiki/Pembrolizumab

    Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.

  5. Merck Banks on Keytruda, Pipeline & Deals Amid Generic Woes - AOL

    www.aol.com/news/merck-banks-keytruda-pipeline...

    Keytruda, approved for several types of cancer, alone accounts for more than 25% of Merck's (MRK) pharmaceutical sales Animal health and vaccine products remain core growth drivers.

  6. Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market

    www.aol.com/news/mercks-keytruda-picks-pace...

    Merck's (MRK) Keytruda is rapidly gaining strength as a key contributor to the company's top line. The Keytruda development program is also progressing well. Merck's Keytruda Picks Up Pace in ...

  7. Health care prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Health_care_prices_in_the...

    The U.S. consumes 3 times as many mammograms, 2.5x the number of MRI scans, and 31% more C-sections per-capita than peer countries. This is a blend of higher per-capita income and higher use of specialists, among other factors. [4] The U.S. government intervenes less actively to force down prices in the United States than in other countries ...

  8. Merck's Experimental Favezelimab/Keytruda Combo Fails ... - AOL

    www.aol.com/mercks-experimental-favezelimab...

    Keytruda has not been approved for the treatment of MSS mCRC. Last month, Merck stopped two Keytruda Phase 3 trials, KEYNOTE-867 and KEYNOTE-630, after underwhelming data .

  9. The extra cost of malpractice lawsuits is a proportion of health spending in both the U.S. (1.7% in 2002) [112] and Canada (0.27% in 2001 or $237 million). In Canada the total cost of settlements, legal fees, and insurance comes to $4 per person each year, [113] but in the United States it is over $16.